n.支气管扩张

Bronchodilatation is a key therapeutic strategy in the management of patients with asthma.
支气管扩张是治疗哮喘患者的关键治疗策略。
The administration of bronchodilators leads to bronchodilatation, thereby improving airflow in the lungs.
使用支气管扩张剂会导致支气管扩张，从而改善肺部的气流。
Beta-2 agonists are commonly used for bronchodilatation in acute asthma attacks."
β2激动剂常用于急性哮喘发作时的支气管扩张。
Corticosteroids combined with bronchodilators provide synergistic bronchodilatation effects.
皮质类固醇与支气管扩张剂联合使用可产生协同的支气管扩张效应。
Inhaled bronchodilators are effective in producing rapid bronchodilatation and relief from symptoms like wheezing.
吸入性支气管扩张剂能有效迅速地实现支气管扩张，并缓解如喘息等症状。
Anticholinergic drugs can also induce bronchodilatation by inhibiting the parasympathetic nervous system's action on airways.
抗胆碱药物通过抑制副交感神经系统对气道的作用，也能引起支气管扩张。
Long-term use of bronchodilators can contribute to chronic bronchodilatation, reducing airway hyperresponsiveness.
长期使用支气管扩张剂有助于实现慢性支气管扩张，降低气道高反应性。
Bronchodilatation therapy should be individualized based on the severity and frequency of the patient's symptoms.
根据患者症状的严重程度和频率，应个性化制定支气管扩张疗法。
Leukotriene antagonists may also offer bronchodilatation benefits for some patients with mild-to-moderate persistent asthma.
白三烯受体拮抗剂也可能为一些中度至持续性轻度哮喘患者提供支气管扩张的好处。
A combination of long-acting bronchodilators and inhaled corticosteroids optimizes bronchodilatation and reduces inflammation in COPD patients.
长效支气管扩张剂和吸入性皮质激素的组合优化了慢性阻塞性肺疾病患者的支气管扩张并减轻了炎症。